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The infrared (IR) spectrum of protonated histamine (histamineH+) was recorded in the 575–1900 cm1
ﬁngerprint range by means of IR multiple photon dissociation (IRMPD) spectroscopy. The IRMPD
spectrum of mass-selected histamineH+ ions was obtained in a Fourier transform ion cyclotron
resonance mass spectrometer coupled to an electrospray ionization source and an IR free electron laser.
A variety of isomers were identiﬁed and characterized by quantum chemical calculations at the B3LYP
and MP2 levels of theory using the cc-pVDZ basis set. The low-energy isomers are derived from
various favourable protonation sites—all of which are N atoms—and diﬀerent orientations of the
ethylamine side chain with respect to the heterocyclic imidazole ring. The measured IRMPD spectrum
was monitored in the NH3 loss channel and exhibits 14 bands in the investigated spectral range, which
were assigned to vibrational transitions of the most stable isomer, denoted A. This imidazolium-type
isomer A with protonation at the imidazole ring and gauche conformation of the ethylamine side chain
is signiﬁcantly stabilized by an intramolecular ionic Np–H+  Na hydrogen bond to the ethylamino
group. The slightly less stable ammonium-type isomer B with protonation at the ethylamino group is
only a few kJ mol1 higher in energy and may also provide a minor contribution to the observed
IRMPD spectrum. Isomer B is derived from A by simple proton transfer from imidazole to the
ethylamino group along the intramolecular Np–H+  Na hydrogen bond via a low barrier, which is
calculated to be of the order of 5–15 kJ mol1. Signiﬁcantly, the most stable structure of isolated
histamineH+ diﬀers from that in the condensed phase by both the protonation site and the
conformation of the side chain, emphasizing the important eﬀects of solvation on the structure and
function of this neurotransmitter. The eﬀects of protonation on the geometric and electronic structure
of histamine are evaluated by comparing the calculated properties of isomer A with those of the most
stable structure of neutral histamine A(n).
1. Introduction
2-(1H-imidazol-4-yl)ethanamine, also known as histamine
(C5N3H9, Fig. 1), is a biogenic monoamine and belongs to
the family of fundamental neurotransmitters.1–3 Histamine
occurs in animal organisms and plant tissues,4 and is synthe-
sized in basophils and mast cells from histidine through
one-step enzymatic decarboxylation. Histamine is of importance
in the immune response to foreign pathogens and involved in
allergic reactions. In this context, histamine triggers the inﬂam-
matory response by dilating the blood vessels, which results in
an enhanced permeability of the vessels and thus in increased
ﬂuid content in the cells. Thus, skin swelling occurs as a
symptom of an allergic reaction. Furthermore, histamine inter-
acts with at least four receptors, denoted H1–4, with diﬀerent
resulting biological activities. For example, the interaction with
Fig. 1 Tautomeric structures Nt and Np of neutral histamine.
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the H2 receptor invokes gastric secretion, which is expected to
produce gastric ulceration.5–8 As histamine occurs under physio-
logical conditions (pH = 7.4) predominantly in its singly
protonated form (>96%),5,9 characterization of isolated
histamineH+ and its interaction with the environment are required
to understand these biophysical processes at the molecular level.
Owing to the two nitrogen atoms of the imidazole unit,
histamine exists in two tautomeric forms (Fig. 1), denoted
Np–H and Nt–H (or N1–H and N3–H). Histamine oﬀers
two basic N atoms for protonation, one at the imidazole ring
(Nt/p) and one at the terminal amino group of the aliphatic
side chain (Na). Protonation at Nt/p generates an imidazo-
lium ion, whereas protonation at Na produces an ammonium
ion. Under physiological conditions, the excess proton is
located at Na due to its higher pKa value of B9.4 as compared
to Nt/p with pKa E 5.8.
9 In addition, as a result of the
ﬂexibility of the ethylamine side chain (Fig. 2), histamine(H+)
can adopt folded gauche and extended trans structures,
yielding a variety of possible conformeric tautomers. A parti-
cular feature of histamine(H+) involves the possibility of
several gauche isomers to form intramolecular N–H(+)  N
hydrogen bonds, which lead to additional stabilization with
respect to the corresponding trans isomers in the gas phase.
In solution, however, the energy gain through solvation
competes with the stabilization through these intramolecular
hydrogen bonds. There might be further intramolecular inter-
actions, like cation–p interactions between the protonated side
chain and the aromaticp-electron system of imidazole.10–13
For a deeper understanding of all these interactions and the
resulting structure–function relationship of this fundamental
neurotransmitter at the molecular level, it is essential to
evaluate the eﬀects of the environment and the charge state
on the structural and energetic properties.
Previous experimental studies of histamine(H+) reveal that
the tautomeric and conformational structure and the proto-
nation site observed strongly depend on its charge state and
the environment. Early X-ray crystallographic studies on ionic
histamine*HBr salts yield an ammonium-type Nt-tautomeric
histamineH+ ion with the protonated ethylamine side chain
in trans conformation.14 Subsequent vibrational analysis of
infrared (IR) and Raman spectra of the related histamine*HCl
salt is consistent with this result.15 Interestingly, X-ray studies
of crystals of neutral histamine grown from dry benzene
solutions reveal a Np-tautomeric form in trans conformation,
with no evidence for contributions from a Nt tautomer,
illustrating the large impact of protonation and counter ions
on the preferred structure of histamine.16 In contrast to the
crystalline phase, the structure of histamineH+ in solution is
more ﬂexible and less well deﬁned. NMR studies in aqueous
solution5,17 conﬁrm that histamine occurs at pH E 7.4 with
>96% as an ammonium monocation of both the Np and Nt
tautomers, with the Nt form being slightly preferred and regarded
as the physiologically active species when interacting, e.g., with
the H1 receptor.
5,9 However, at 37 1C the reported diﬀerences in
free energy are less than 4 kJ mol1, so both tautomers may
contribute substantially.8 In addition, the population of gauche
and trans conformations of histamineH+was estimated as 45 and
55% in aqueous solution, respectively.5 The analyses of more
recent IR and Raman spectra in conjunction with calculations at
the B3PW91/6-31+G* level are consistent with respect to that
the trans Nt-tautomeric ammonium isomer is the predominant
isomer in water.18 Similar to the protonated species, early
13C-NMR studies indicate the preference for the Nt tautomer
also for neutral histamine in aqueous solution.19 More recent IR
and Raman spectra of histamine in H2O and D2O as well as
calculations based on a continuum solvent model conﬁrm that the
Nt tautomer in gauche conformation is the most stable isomer of
neutral histamine in aqueous solution.20 However, as diﬀerent
calculations do not yield uniform results, the structure of neutral
histamine in solution is still under debate.20–25
In order to eliminate the strong impact of the environment on
the structure of histamine(H+), experimental studies for these
species isolated in the gas phase are required. However, such
studies are scarce. Pioneering microwave experiments reveal the
presence of one Np and three Nt tautomers of neutral histamine
in a molecular beam expansion.26 Their structural identiﬁcation was
unambiguously conﬁrmed by quantum chemical calculations.26,27
In contrast to the condensed phase, all structures observed in
the gas phase are gauche isomers. The most stable structure,
denoted A(n), is a gauche Np tautomer stabilized by an
intramolecular Np–H  Na hydrogen bond.26,27 The only
experimental data available for isolated histamineH+ are de-
rived from mass spectrometric experiments, which do
however not provide any direct structural information.28,29
No spectroscopic data are available for histamineH+ in the
gas phase. Thus, the current IR spectroscopic study provides
the ﬁrst experimental determination of the geometry of the
protonated species free from interference with solvation
eﬀects. There are a large variety of quantum chemical studies,
which investigate in some detail the structural, energetic and
vibrational properties of isolated histamineH+ isomers and the
eﬀects of solvation.21,22,28,30–34 These calculations predict the
gauche imidazolium ion (isomer A, Fig. 3) to be the most stable
structure of the isolated molecule, followed closely in energy by
the gauche ammonium-type Nt tautomer (isomer B).28,31
There are twomajor strategies to IR spectroscopy of molecular
ions and clusters in the gas phase, and their application to
protonated aromatic ions (AH+) has been reviewed recently.35,36
The ﬁrst technique involves single-photon dissociation of weakly
bound cluster ions using table-top IR lasers based on diﬀerence
frequency mixing or optical parametric oscillators.37–39 This
approach has initially been applied to protonated phenol40–42
and benzene,43,44 and since then to a large variety of other
AH+ ions.45–50 This method can also be applied to weakly
bound isolated AH+ ions with low dissociation thresholds.51–53
Fig. 2 Structure and atomic labels of isomer A of histamineH+
(C5H10N3
+) at the B3LYP/cc-pVDZ level. The dihedral angles f1
and f2 deﬁne the conformation of the various possible isomers of
histamineH+, while the position of the protons at Np, Nt and Na
deﬁnes tautomeric isomers.
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In an elegant approach,54–56 a variety of simple protonated
neurotransmitters were prepared by ionization-induced intra-
cluster proton transfer occurring in a hydrogen-bonded
phenol–neurotransmitter cluster. This approach produces a
phenoxy-neurotransmitterH+ dimer, the structure of which can
subsequently be probed by IR photodissociation monitoring the
loss of the phenoxy tag. Alternatively, the neurotransmitterH+
can directly be generated upon post-ionization fragmentation and
then probed by IR multiple photon dissociation (IRMPD).
Owing to the complex photochemical production mechanism,
the detected protonation site may however not necessarily be
the energetically most favorable one of the isolated neuro-
transmitterH+. In addition, this approach is limited to neuro-
transmitters and biomolecules, which can be transferred into the
gas phase by thermal heating. The second major strategy involves
IRMPD of strongly bound isolated ions using intense IR free
electron lasers.35,36,57–63 In the IRMPD process, the ion absorbs
in a noncoherent fashion sequentially multiple IR photons until
the lowest dissociation threshold is reached.36 In recent years,
IRMPD has successfully been coupled to electrospray ioniza-
tion (ESI) sources to spectroscopically characterize AH+
ions derived from larger biomolecules36,64–67 and polycyclic
aromatic hydrocarbon molecules,68–71 as well as metal–organic
complexes.72–76 An elegant alternative route to unravel the
protonation site and conformations of protonated biomolecules
and their clusters involves IR hole-burning spectroscopy of
ESI-generated ions in cryogenic ion traps.77–79
In a recent campaign, we recorded IRMPD spectra of a
series of ESI-generated protonated neurotransmitters in the
ﬁngerprint range in a Fourier transform ion cyclotron reso-
nance (FT-ICR) mass spectrometer, which was coupled to the
IR beamline of the Free Electron Laser for Infrared eXperiments
(FELIX). A thorough account of the results obtained for
dopamineH+ and serotoninH+ has been given elsewhere.12,13
The present work provides a detailed analysis of the IRMPD
spectrum of histamineH+ utilizing quantum chemical
calculations at the B3LYP and MP2 levels of theory. The ﬁrst
spectroscopic data for this ion establish that the preferred
protonation site of this fundamental neurotransmitter
molecule in the gas phase is at the imidazole ring and not at
the ethylamine side chain. In this respect, protonated
histamine diﬀers from all related neurotransmitterH+ ions
studied so far,12,13,54–56 which exclusively prefer protonation at
the alkylamino side chain.
Fig. 3 Structures and relative energies (DE, top) and free energies (DG, bottom) of various isomers of histamineH+ derived at the B3LYP/
cc-pVDZ level. Corresponding MP2/cc-pVDZ values are given in parentheses. All energies are given in kJ mol1.
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2. Experimental and theoretical techniques
The IRMPD spectrum of mass-selected histamineH+ ions was
obtained in the 575–1900 cm1 ﬁngerprint range using the
same strategy employed previously for related protonated
neurotransmitters12,13 and polycyclic aromatic hydrocarbon
molecules.68–70 Brieﬂy, the IRMPD spectrum of histamineH+
was recorded in a FT-ICR mass spectrometer coupled to the
IR beamline of FELIX.80,81 Histamine was purchased from
Sigma-Aldrich (product number H7125) and used without
further puriﬁcation. HistamineH+ ions were produced in an
ESI source by spraying a B3  105 molar solution of
histamine dissolved in water/methanol (1 : 4) at a ﬂow rate
ofB10 mL min1. After accumulation and thermalization in a
hexapole trap for 4 s, all ions were transferred into the ICR
trap. Subsequently, histamineH+ ions were mass selected and
irradiated in the ICR trap for 3 s with IR laser radiation from
FELIX operating at a repetition rate of 5 Hz. The macropulse
energy varied between 65 and 31 mJ measured near 950 and
1685 cm1, respectively (see Fig. 4 for the detailed wavenumber
dependence). The bandwidth of the FELIX radiation is speci-
ﬁed asB0.5% of the central wavelength, which corresponds to
5 cm1 at n = 1000 cm1. The wavenumber step size varied
between 3 and 8 cm1. Under the given experimental condi-
tions, the only major fragmentation channel observed upon
IRMPD of histamineH+ (m/z= 112) was loss of NH3 leading
to fragment ions with m/z = 95. (A second higher-energy
fragmentation channel yielding m/z = 83 is weaker than 10%
of the m/z= 95 channel and thus neglected for further analysis,
in particular because it exhibits the same IR action spectrum.)
Parent and fragment ion intensities were monitored as a
function of the laser frequency (Fig. 4), and the IRMPD yield
shown in Fig. 5 was calculated as the integrated intensity ratio
I95/(I95 + I112), which was linearly normalized for variations in
the laser intensity displayed in Fig. 4. The IRMPD spectrum
reveals 14 major bands labelled A–O in the spectral range
investigated, and their positions, widths, and assignments are
listed in Table 1. As expected, the depletion spectrum of the
m/z = 112 parent ion is similar to the appearance spectrum of
the m/z = 95 daughter ion. The depletion of the parent ion
signal exceeds 20% at most intense resonances indicating
Fig. 4 Ion currents of histamineH+ (m/z = 112) and the fragment
channel with m/z= 95 (loss of NH3) recorded in the ﬁngerprint range
(575–1680 cm1). The spectrum was actually scanned up to 1900 cm1
but no transition was detected beyond 1600 cm1 (band O). The
variation in the IR laser intensity is given as dashed line. The positions
and vibrational assignments of the bands A–O are listed in Table 1.
Fig. 5 IRMPD yield of histamineH+ linearly normalized for IR
laser intensity variations compared to linear IR absorptions spectra
of the lowest-energy isomers A–F of histamineH+ in energetic order
(DE in kJ mol1) calculated at the B3LYP/cc-pVDZ level. The IR
spectra are scaled by 0.98 and stick spectra are convoluted using
FWHM= 30 cm1. The intensities of all calculated spectra are drawn
on the same scale. The intensity of the intense transition of B is cut
atB50%. The IR spectra calculated for the high-energy isomers G–J
are available in Fig. S5 in ESI.w
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eﬃcient IRMPD. As the IRMPD yield is normalized for parent
ion ﬂuctuations, it exhibits better signal-to-noise ratio than the
depletion signal and will be compared to the calculated spectra.
The width of the IRMPD bands of typically B40 cm1 arises
from a variety of reasons. First, several overlapping vibrational
transitions of a single isomer as well as signals from several
isomers may contribute to the observed peaks resulting in
spectral congestion. The ﬁnite laser bandwidth of B0.5%
(i.e., 3–10 cm1) leads to additional broadening, along with
an unresolved rotational ﬁne structure of the ions at T= 300 K
in the ICR cell. Rotational band contour simulations using the
rotational constants of histamineH+ (isomer A) calculated at
the B3LYP/cc-pVDZ level (A = 4.72 GHz, B = 1.44 GHz,
C = 1.15 GHz) suggest that up to 15 cm1 of the observed
width may be attributed to the unresolved rotational ﬁne
structure. Furthermore, the multiple photon absorption process
itself results in heating of the ions during the long irradiation
time which in turn leads to additional broadening.36,82 The most
narrow band at 607 cm1 has a width of 23 cm1, which is close
to the width expected from the rotational contour (15 cm1)
and the laser resolution at this frequency (3 cm1). Despite its
multiple photonic nature, the IRMPD spectrum predominantly
reﬂects the absorption of the ﬁrst IR photon (the reader
is referred to ref. 36 for a recent review of the IRMPD
mechanism) and thus justiﬁes direct comparison with a calcu-
lated linear one-photon IR absorption spectrum.
Table 1 Experimental vibrational frequencies (in cm1) of histamineH+ extracted from its IRMPD spectrum (Fig. 6) compared to frequencies of
the isomers A and A(n) of protonated and neutral histamine calculated at the B3LYP/cc-pVDZ level
HistamineH+a, nexp HistamineH+ Ab, ncalc Histamine A(n)b, ncalc Vibrationc
1598 (34) O 1623 (95) 1577 (10) n5(Im) = sCC/sCN/bNH/bCH
1606 (30) 1605 (24) bNH2(scissor)
1515 (—) N 1527 (12) 1474 (25) n6(Im) = sCC/sCN/bCH/bCH
1453 (B60) M 1471 (10) — bNH(Nt) of excess H
+
1456 (6) 1453 (3) bCH2(scissor, C7)
1425 (25) 1423 (10) bCH2(scissor, C6)
1389 (58) L 1403 (71) 1403 (33) n7(Im) = sCC/sCN/bNH/bCH
1359 (—) K 1382 (6) 1383 (10) bCH2(wag, C7) and tNH2
1336 (2) 1335 (9) bCH2(wag, C6) and bCH2(twist, C7)
1293 (35) I 1296 (29) 1359 (22) sCC/sCN/bCH/bNH and bCH2(wag, C6) and bCH2(twist, C7)
1288 (13) 1288 (2) bCH2(twist, C6) and bCH2(wag, C7) and tNH2
1255 (17) 1233 (2) n10(Im) = sCN(sym) and bCH2(twist, C6) and bCH2(wag, C7)
1224 (10) 1211 (5) n8(Im) = sCN and bCH2(twist, C6) and bCH2(twist, C7)
1165 (8) 1252 (12) n9(Im) = bNH/bCH
1136 (26) 1126 (3) n13(Im) = sCN and bCH2(twist, C6) and tNH2
1107 (B30) H 1117 (111) 1084 (64) bNH(Np) = n12(Im)
1075 (38) G 1078 (117) 758 (21) n21(Im) = gNH(Np)
1070 (12) 1116 (1) n11(Im) = sCN(NtC4)/bCH
1045 (12) 1058 (10) sCC(C6C7) and sCN(C7Na)
997 (B55) F 1021 (26) 1009 (19) sCN(C7Na) and tNH2
965 (26) 994 (8) n14(Im) = sCN(sym, Np)
941 (11) 937 (31) bCH2(twist, C6 and C7) and tNH2
909 (B60) E 926 (18) 919 (18) n15(Im) = sCN(sym, Nt)
875 (15) 881 (21) sCC(C6C7)
838 (12) 836 (34) sCC(sym, C5C6 and C6C7) and bCH2(twist, C6)
830 (40) D 820 (24) 820 (25) n17(Im) = gCH (in phase, C2 and C4)
788 (B35) C 778 (2) 787 (25) n16(Im) = gCH (out of phase, C2 and C4)
685 (17) 680 (7) n18(Im) = gCN/CC
685 (53) B 671 (52) — gNH(Nt) of excess H
+
618 (6) 610 (7) n20(Im) = gCN/CC
607 (23) A 607 (49) 652 (22) n19(Im) = gCN/CC
a Peak positions and labels taken from the IRMPD spectrum in Fig. 6. The widths (FWHM) are given in parentheses. b IR intensities in km mol1
are given in parentheses. Harmonic frequencies are scaled by 0.98. c The notation s, g, b, and t refers to stretch, out-of-plane bend, in-plane bend,
and torsional modes, respectively. ni(Im) denote corresponding normal modes of imidazole taken from ref. 97 and 98.
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Quantum chemical calculations at the B3LYP/cc-pVDZ
and MP2/cc-pVDZ levels were performed for histamine(H+)
to identify various low-lying isomers on the potential energy
surface and to evaluate their structural, energetic, and IR
spectral properties.83 Reported relative (free) energies DE
and DG (298 K) include harmonic vibrational zero-point
energy corrections scaled with a factor of 0.98 (B3LYP) and
0.97 (MP2).12,13 If not stated otherwise, all coordinates were
relaxed to locate stationary points on the potential energy
surface. For all stationary points, frequency analysis ensured
their nature as a minimum or transition state. Theoretical IR
stick absorption spectra are convoluted with Gaussian line
proﬁles using FWHM = 30 cm1 to facilitate convenient
comparison with the experimental IRMPD spectrum.
A natural bond orbital (NBO) analysis was performed to
evaluate charge distributions in histamine(H+). For the two
most stable histamineH+ isomers, which are close in energy
(A and B), higher levels of theory up to MP2/cc-pVQZ and
CCSD(T)/cc-pVDZ were applied to ensure their energetic order.
3. Results and discussion
3.1 Vibrational and isomer assignment of IRMPD spectrum
Extended quantum chemical calculations were conducted at
the B3LYP/cc-pVDZ and MP2/cc-pVDZ levels to establish
the vibrational and isomer assignment of the transitions
observed in the experimental IRMPD spectrum of histamineH+.
The structures and relative energies (DE and DG) of the most
stable isomers labelled A–J resulting from a detailed search on
the potential energy surface of the isolated ion are shown in
Fig. 3. Only structures with protonation at one of the basic
nitrogen atoms Np/t/a were investigated. In agreement with
previous calculations,28,30,31 the three most stable isomers A–C
are derived from gauche conformers of the neutral Nt tautomer
by protonation at either Np (A, C) or Na (B). Thus, A and C are
imidazolium ions, whereas B corresponds to an ammonium
isomer. In all three isomers, the (protonated) amino group
of the ethylamine side chain points toward the imidazole ring
(901o f1 o 901, Fig. 2). The isomers A and B are similar in
energy (to within 10 kJ mol1) and by far the most stable
structures because they are both substantially stabilized by
strong and short intramolecular N–H+  N hydrogen bonds
(R = 1.79 and 1.59 A˚). Actually, both isomers can be inter-
converted into each other by simple proton transfer along the
N–H+  N hydrogen bond through a transition state with a low
barrier calculated to be of the order of 5–15 kJ mol1 (vide
infra). Structure C is B30–40 kJ mol1 less stable than A and
seems to slightly beneﬁt from a weak and long CH  N contact
(R= 2.45 A˚). Two more trans conformers of imidazolium ions,
denoted D and E, with the amino group of the ethylamine side
chain pointing away from the imidazole unit (f1 > 901 or f1o
901), are located B50–60 kJ mol1 above A. Isomer F is the
lowest-energy trans ammonium isomer at DEE 70–80 kJ mol1.
The two structures G and H are gauche and trans ammonium
isomers with the imidazole proton at Np (rather than at Nt) and
DE E 90–100 kJ mol1. The isomers I and J with two protons
at Nt are much higher in energy (DE E 250 kJ mol1), similar
to isomers with two protons attached to Np (not shown).
Protonation at C atoms of the imidazole ring was not investi-
gated, as previous MP2/6-311G(2df,2pd) calculations for
imidazoleH+ revealed that protonation at the basic N atom is
favoured by around 150 kJ mol1.84,85 Protonation at the
aliphatic C atoms of the ethylamine side chain is expected to
be even less favourable.86 For completeness, we note that for all
isomers depicted in Fig. 3 there are two symmetry-equivalent
minima on the potential energy surface with the same energy
obtained by reﬂection at the imidazole plane.21 However, their
interconversion involves relatively high barriers and the resulting
tunnelling splittings are not resolved at the present spectral
resolution. For example, in isomer A the two heavy atoms of
the –CH2–NH2 unit in the side chain may either be above or
below the aromatic plane. The barrier between these two
equivalent minima amounts to 29.2 kJ mol1 at the B3LYP/
cc-pVDZ level. Thus, for all purposes of the present work, we
can neglect the consequences of the existence of symmetry-
equivalent enantiomers.
Interestingly, the energy diﬀerence between the two most
stable isomers A and B is small and strongly depends on the
theoretical level (Fig. 3, Table 2). Whereas the imidazolium
ion A is calculated to be signiﬁcantly more stable than the
ammonium isomer B at the B3LYP/cc-pVDZ level (DE =
6.2 kJ mol1, DG= 6.3 kJ mol1), the reversed energetic order
is predicted at the MP2/cc-pVDZ level, although with a much
smaller energy gap (DE= 1.6 kJ mol1, DG= 1.7 kJ mol1).
In an eﬀort to address this important issue of the relative
stability of these two isomers, their (free) energies are evalu-
ated at a variety of theoretical levels and basis sets (Table 2).
The diﬀerences between DE and DG are less than 0.3 kJ mol1
at all theoretical levels considered, indicating that entropy
eﬀects are negligible for this problem. This result is expected
because of the similar structures of both isomers. Density
functional calculations using B3LYP and M06-2X show a
Table 2 Relative energies (DE) and relative free energies DG
(in kJ mol1) of the two most stable isomers of histamineH+ (A, B)
calculated at various levels of theorya
DE DG
A B A B
B3LYP/cc-pVDZ 0.0 6.2 0.0 6.3
B3LYP/aug-cc-pVDZ 0.0 8.0 0.0 8.2
B3LYP/cc-pVTZ 0.0 9.1 0.0 9.2
B3LYP/aug-cc-pVTZ 0.0 9.2 0.0 9.4
B3LYP/cc-pVQZ 0.0 9.2 0.0 9.5
B3LYP/aug-cc-pVQZ 0.0 9.3 0.0 9.5
M06-2X/cc-pVDZ 0.0 3.6 0.0 3.7
M06-2X/aug-cc-pVDZ 0.0 5.5 0.0 5.6
M06-2X/cc-pVTZ 0.0 6.6 0.0 6.9
M06-2X/aug-cc-pVTZ 0.0 7.0 0.0 7.1
M06-2X/cc-pVQZ 0.0 7.4 0.0 7.7
M06-2X/aug-cc-pVQZ 0.0 7.5 0.0 7.7
MP2/cc-pVDZ 1.6 0.0 1.7 0.0
MP2/aug-cc-pVDZ 0.0 0.4 0.0 0.3
MP2/cc-pVTZ 0.0 1.0 0.0 0.9
MP2/aug-cc-pVTZ 0.0 1.0 0.0 0.9
MP2/cc-pVQZ 0.0 1.2 0.0 1.2
CCSD/cc-pVDZ 0.0 4.2 0.0 4.2
CCSD(T)/cc-pVDZ//CCSD/cc-pVDZ 0.0 0.3
CBS-QB3 0.0 3.5 0.0 3.5
a Relative energies in this table include unscaled zero-point energy
corrections.
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clear energetic preference for A, with energy gaps of DE= 9.3
and 7.5 kJ mol1 using the aug-cc-pVQZ basis set, respec-
tively. Interestingly, also the MP2 level preicts A to be more
stable than B when using larger basis sets, although the energy
gap is only of the order of 1 kJ mol1 using the cc-pVQZ or
aug-cc-pVTZ basis sets. Similarly, the CCSD(T)/cc-pVDZ//
CCSD/cc-pVDZ level yields only a small energy preference for
A (0.3 kJ mol1). In contrast, the popular CBS-QB3 level
optimized for energy calculations arrives at a larger energy gap
of DE= 3.5 kJ mol1 in favour of A. In summary, all levels of
theory considered in Table 2 predict A to be more stable than
B when using suﬃciently large basis sets, with energy diﬀer-
ences ranging from 1 to 10 kJ mol1. Somewhat larger energy
gaps are predicted at the density functional theory levels,
whereas smaller gaps are obtained at correlated levels.
Although high-level correlated calculations are required for
establishing a more reliable energy diﬀerence between A and
B, such calculations are not available in the literature, and
beyond our computing resources and the scope of the
present work.
As already noted, interconversion between A and B is
achieved by simple proton transfer along the Np  H+  Na
coordinate, which is accompanied by only modest structural
rearrangements of the aromatic imidazole ring and the alipha-
tic side chain. Selected structural parameters for A and B and
the transition state TS are listed in Table 3 and more details
are given in Fig. S1 and S2 in ESI.w As can be seen, the
main diﬀerences between both minima are related to the
Np  H+  Na hydrogen bond. Calculations reveal that
the barriers between both minima are of the order of
5–15 kJ mol1 depending on the theoretical level and the
direction of the proton shift. For example, the barriers are
VA-B = 10.4 and VB-A = 4.6 kJ mol
1 at the B3LYP/
cc-pVDZ level (see Fig. S3 in ESIw for a detailed potential
energy surface scan). Single-point calculations using the larger
aug-cc-pVDZ basis set yield slightly higher barriers of 13.9
and 10.0 kJ mol1, respectively. Similar values of 5.7 and
8.9 kJ mol1 are obtained at the MP2/cc-pVDZ level, which
again slightly increase to 10.0 and 11.2 kJ mol1 using the
larger aug-cc-pVDZ basis. Thus, although the barriers are
modest, they are signiﬁcant and large enough to support two
separate minima in an asymmetric double-well potential.
The strength of the H-bond in A can roughly be estimated
as B50 kJ mol1 by the energy diﬀerence between the two
isomers D and A. In a similar fashion, the stabilisation energy
of the H-bond in B is estimated asB70 kJ mol1 by the energy
diﬀerence between F and B. Indeed, the slightly stronger
H-bond in B is consistent with a shorter NH+  N bond
distance as compared to A (1.59 vs. 1.79 A˚). The Np  Na
distances in A and B are relatively large (2.66 and 2.59 A˚)
and the H-bonds are deviating signiﬁcantly from linearity
(y = 1361 and 1471). As expected, the Np  Na distance is
shortest at TS (2.49 A˚), and the Np  H+  Na hydrogen
bridge is slightly asymmetric, with the Na–H bond being
slightly shorter than the Np–H bond at the B3LYP level
(1.27 vs. 1.31 A˚) and the reversed situation at the MP2 level
(1.34 vs. 1.24 A˚). All these observations are consistent with the
moderate ionic H-bond strengths in both isomers and in line
with the clear formation of a double-well potential separating
the two minima A and B by an appreciable barrier. For
comparison, although the more strongly bound protonated
ammonia dimer, N2H7
+, features a much stronger linear
N–H+  N hydrogen bond with D0 E 110 kJ mol1, the
potential still features a symmetric double minimum potential
with a barrier of 4 kJ mol1.87
The NBO population analysis for the isomers A and B of
histamineH+ is detailed in Fig. S4 in ESI.w In isomer A,
most of the additional positive charge is distributed over the
imidazole ring system (+0.84 e), and only little charge is
located on the ethylamine side chain (+0.16 e), consistent
with the view of an imidazolium ion. The situation is reversed
in B, with most of the excess charge located on the protonated
ethylamine side chain (+0.88 e) and little charge on the
heterocyclic ring (+0.12 e), consistent with the notion of
an ammonium ion. In both isomers, the proton in the
Np  H+  Na hydrogen bond carries high positive partial
charge (B0.5 e). In TS, the excess proton also carries +0.49 e
and the rest of the positive charge is nearly equally distributed
between the imidazole (+0.21 e) and ethylamine chain
(+0.31 e), as expected for an intermediate between an imida-
zolium and an ammonium ion.
In the next step, we compare in Fig. 5 the measured IRMPD
spectrum of histamineH+ to linear IR absorption spectra
calculated for the low-energy isomers A–F shown in Fig. 3.
IR spectra of the less stable isomers with DE > 100 kJ mol1
are reproduced in Fig. S5 of ESI.w For this purpose, we
employ spectra derived at the B3LYP level, because this
theoretical approach has shown to provide reliable IR spectra
of protonated aromatic molecules and their complexes,68–70,74
including the related protonated neurotransmitter molecules
serotoninH+ and dopamineH+.12,13 In contrast, MP2 calcu-
lations often fail to properly reproduce IR spectra of (proto-
nated) aromatic molecules.68,70,88
Inspection of Fig. 5 immediately reveals satisfactory corres-
pondence between the measured IRMPD spectrum of
histamineH+ and the spectrum calculated for the most stable
isomer A, with respect to both peak positions and relative
intensities. At this stage, one has to bear in mind that the
Table 3 Selected bond distances (in A˚), bond and dihedral angles (in 1),
and relative energies and free energies at 298 K (in kJ mol1) of the
two most stable isomers A and B of histamineH+ and the transition state
TS calculated at the B3LYP/cc-pVDZ and MP2/cc-pVDZ levels
(Fig. 3 and Fig. S2 in ESIw)a,b
A B TS
B3LYP MP2 B3LYP MP2 B3LYP MP2
f1 57.9 59.4 56.9 59.4 53.5 55.9
f2 36.2 36.4 37.3 38.6 34.2 34.7
RNa  H 1.790 1.742 1.106 1.092 1.271 1.342
RNp  H 1.059 1.065 1.587 1.614 1.309 1.238
RNt  H 1.016 1.019 1.015 1.018 1.015 1.018
RNp  Na 2.659 2.626 2.586 2.592 2.491 2.485
y 136.4 137.3 146.9 146.0 149.8 148.8
DE 0.0 1.6 6.2 0.0 10.4c 8.9c
DG 0.0 1.7 6.3 0.0
a f1 = dihedral angle C5–C6–C7–Na, f2 = dihedral angle
Np–C5–C6–C7, y = angle Np–H–Na. b Corresponding data for the
other isomers C–J are listed in Table S1 in ESI.w c Without zero-point
energy corrections.
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multiple photonic nature of the IRMPD process may cause
minor but noticeable deviations from a linear IR absorption
spectrum, such as modest red shifts of 10–30 cm1 and slight
modiﬁcations of relative IR intensities of close-lying vibra-
tional resonances.36,82 Both eﬀects are visible here and
discussed in more detail below. Clearly, the agreement between
the IRMPD spectrum and the IR spectrum calculated for B is
much worse as compared to A. For example, the very intense
NH bend vibration (bNH) of the ammonium group predicted
at 1480 cm1 is not visible in the measured spectrum,
suggesting at most only minor population of B in the sampled
histamineH+ ion cloud. Actually, anharmonic calculations
discussed below predict the intense bNH transition to occur
near 1400 cm1, again in a spectral range where only little
intensity is detected in the experimental spectrum. Further
features of the IRMPD spectrum, which are not reproduced
by the calculated spectrum of B, include the intense G/H
doublet and the high intensity of bands B and O. In addition,
the spectrum of B predicts an intense band near 1250 cm1,
which is completely absent in the measured spectrum. All these
observations suggest that B does not provide major contribu-
tions to the experimental IRMPD spectrum. The same con-
clusion holds also for the higher lying isomers C–J (Fig. 5 and
Fig. S5 in ESIw). As an example, the spectra of C–J all lack
the intense G/H doublet detected in the IRMPD spectrum.
In addition to spectroscopic arguments, thermodynamic
considerations support the assignment of the spectrum mainly
to isomer A. Assuming thermodynamic equilibrium, a tem-
perature of 300 K, and a free energy diﬀerence of 5 kJ mol1
between A and B, the Boltzmann population of B is expected
to be of the order of only 10%. As the ESI process is quite
energetic and the barriers for interconversion between A and B
are quite low, the assumption of thermodynamic rather than
kinetic control seems to be a realistic hypothesis for estimating
the formation ratio of the two histamineH+ isomers in the
ESI source connected to the hexapole trap used for ion
accumulation and thermalization. The spectra in Fig. 5 suggest
that the contribution of B to the IRMPD spectrum is well
below 30%. This translates in a minimum energy gap of
DG = 2.5 kJ mol1 between A and B.
On the basis of thermodynamic and spectroscopic considera-
tions, isomer A is clearly identiﬁed as the major carrier of the
measured IRMPD spectrum. Hence, the vibrational assignment
of the observed transitions in Table 1 is to normal modes of A.
This table compares the peak positions of the IRMPD spectrum
of histamineH+ with the vibrational frequencies and IR
intensities calculated for isomer A of histamineH+ and isomer
A(n) of neutral histamine in the considered 600–1650 cm1
frequency range. The corresponding IR spectra are directly
compared in Fig. 6. Several bands in the IRMPD spectrum of
histamineH+ correspond mainly to single, relatively intense
transitions calculated for isomer A (e.g., bands A, B, G, H, L,
and O), whereas other bands are due to more than one
signiﬁcant vibrational mode. The maximum deviation of the
positions of the experimental band maxima from the frequen-
cies calculated for A is 25 cm1, with an average deviation of
less than 16 cm1. This result conﬁrms the vibrational and
isomer assignments given in Table 1. In addition, all modes with
calculated oscillator strengths larger than B10–15 km mol1
are visible in the experimental spectrum. This threshold
intensity is typical for IRMPD detection of molecular ions of
this size.70
Band A at 607 cm1 in the IRMPD spectrum is assigned to
an out-of-plane ring deformation mode of imidazole, corres-
ponding to n19(Im). Band B at 685 cm
1 is attributed to the
out-of-plane NH bend (gNH) at Nt, a mode which is absent for
neutral A(n). Transition D at 830 cm1 arises from an out-of-
plane CH bend (gCH) of the imidazole ring, n16(Im). The weak
bands E and F at 909 and 997 cm1 are mainly assigned to the
imidazole ring stretching modes n15(Im) and n14(Im), respec-
tively. The intense band G at 1075 cm1 is attributed to the
out-of-plane NH bend (gNH) at Np, i.e. a proton motion
perpendicular to the Np–H+  Na hydrogen bond. Since the
H-bond is much stronger in the protonated species, this mode
experiences a large blueshift compared to neutral A(n) from
758 to 1078 cm1. Also the IR intensity is substantially
enhanced from 21 to 117 km mol1 in the ionic species. The
shoulder H at 1107 cm1 arises from the in-plane NH bend
(bNH) of the proton at Np, corresponding to n12(Im). Inter-
estingly, the blueshift of this mode upon protonation from
1084 to 1117 cm1 is much smaller than for gNH. The weak
transition I at 1293 cm1 is assigned to a highly-coupled mode,
delocalized over imidazole and the alkylamine side chain
(Table 1). Band L at 1389 cm1 is mainly due to n7(Im). Band
M at 1453 cm1 is dominated by the in-plane NH bend (bNH)
at Nt, a mode which is again absent in neutral A(n). Finally,
the main intensity of band O at 1598 cm1 arises from the
n5(Im) ring mode, with a smaller contribution in the red wing
coming from the NH2 scissoring mode of the terminal
amino group.
In general, there is satisfactory agreement between the
measured IRMPD spectrum and the linear absorption spec-
trum calculated for A. There are, however, several notable
discrepancies, most of which can be attributed to the multiple
photonic nature of the IRMPD process. First, although the
Fig. 6 Comparison of the IRMPD spectrum of histamineH+ with
the linear IR absorption spectra of the most stable isomers of
histamineH+ (A) and neutral histamine (A(n)) calculated at the
B3LYP/cc-pVDZ level (Table 1).
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IRMPD technique reﬂects mainly the absorption of the ﬁrst
photon and thus justiﬁes in zero-order direct comparison with
a linear absorption spectrum, a certain threshold intensity
Ith of the vibrational transition is required to allow for its
detection. In the present case, Ith lies near 10–15 km mol
1.
A second eﬀect of the IRMPD process on the IR spectrum of a
molecule are redshifts of the transitions due to anharmonic
vibrational couplings. Depending on the vibrational mode of
the molecular ion, this redshift typically varies between 10 and
30 cm1 in the ﬁngerprint range. It can often be absorbed in
the scaling factor, which is then slightly lower than that
obtained when considering a linear IR spectrum. Nonetheless,
for heavily aﬀected modes this redshift may not fully be
compensated for by the scaling factor, as is seen here for the
intense n5(Im) mode (band O), which appears in the IRMPD
spectrum 25 cm1 lower than the value predicted after scaling.
A further side eﬀect of anharmonic coupling is that IRMPD
intensities for two close-lying transitions are modiﬁed such
that the lower-frequency mode gains intensity. One such
example in the IRMPD spectrum of histamineH+ is the
doublet G/H.
Several vibrational modes related to the intramolecular
Np  H+  Na H-bond in the isomers A and B exhibit rather
large anharmonicity, which is not adequately compensated for
by using a scaling factor applied to harmonic frequencies.
In an eﬀort to estimate the eﬀects of anharmonicity on the IR
spectra in a more sophisticated fashion, anharmonic frequen-
cies are determined at the B3LYP/cc-pVDZ level using the
procedure implemented in GAUSSIAN09. The resulting
anharmonic spectra are compared in Fig. S6 in ESIw directly
to those obtained by harmonic calculations treated with a
scaling factor. For isomer A, both IR spectra are very similar
in the considered ﬁngerprint range (500–2000 cm1), indi-
cating that the application of a scaling factor to harmonic
spectra provides a reliable description of the IR spectrum of A
in this spectral range. In fact, the agreement of the IRMPD
spectrum with the calculated anharmonic spectrum appears to
be better than with the scaled harmonic spectrum (Fig. 7), in
particular concerning the position of band O and the splitting
between bands G and H. As expected, the Np–H proton donor
stretch mode (sNH) is the vibration with the largest frequency
shift upon taking anharmonicity into account, leading to a
reduction from 2860 to 2376 cm1 (Fig. S6 in ESIw). The latter
value is still outside the scanned range and does not aﬀect the
comparison of the spectra in Fig. 5 and 7. In contrast, the
spectrum of isomer B is signiﬁcantly modiﬁed in the 500–
2000 cm1 range when anharmonicity is included (Fig. S6 in
ESIw). First, the Na–H proton donor stretch mode (sNH) is
redshifted from 2260 to 1317 cm1 and dominates the calcu-
lated spectrum of B in the range considered for the IRMPD
spectrum. Second, the frequency of the Na–H in-plane bend
(bNH) is also reduced from 1476 to 1403 cm
1. These modi-
ﬁcations to the simulated IR spectrum of B predict two very
intense transitions near 1300 and 1400 cm1, in large disagree-
ment with the experimental IRMPD spectrum. This result may
be taken as further evidence that isomer B does not signi-
ﬁcantly contribute to the IRMPD spectrum.
In an eﬀort to estimate the eﬀects of the possibly large
amplitude motion of the proton in the Np  H+  Na bridge,
the IR spectra of A, B, and TS are compared in Fig. S7 in
ESI.w This comparison suggests that the excess proton is
indeed largely localized on the imidazole moiety. Although
the spectra of A and TS are quite similar in most parts of the
spectral range considered, the spectrum of A reproduces the
G/H double peak, whereas the spectrum of TS does not.
At this stage, it is interesting to realize that the ESI-
generated histamineH+ isomer identiﬁed by IRMPD in the
gas phase (A) is diﬀerent from those found in solution, which
are gauche and trans isomers of Na-protonated Nt and Np
tautomers.5,9,17,18 As already mentioned, the stabilization
induced by solvation of the ammonium group in aqueous
solution overrides the eﬀects of intramolecular H-bonding to
the imidazolium ion. This observation implies that during the
ESI process, the proton is transferred from Na to Np. As this
simple proton transfer occurs via a low barrier along the
Np  H+  Na coordinate and involves only little structural
rearrangements of the imidazole ring and the aliphatic side
chain, it may readily occur during the ESI process.
In line with low-energy collision-induced dissociation (CID)
experiments,89 the only signiﬁcant fragment observed upon
IRMPD of histamineH+ (m/z= 112) corresponds to elimina-
tion of NH3, leading to a fragment ion with m/z = 95. Since
both dissociation processes, CID and IRMPD, occur on the
Fig. 7 Comparison of the IRMPD spectrum of histamineH+ with IR
spectra of isomer A using the harmonic (scaling factor 0.98) and
anharmonic approximation.
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ground electronic state, NH3 loss appears to be the lowest-
energy fragment channel. In an eﬀort to identify plausible
structures of the m/z = 95 fragment, several possible isomers
are calculated at the B3LYP/cc-pVDZ level. The six consid-
ered structures denoted FN_95 with N = I–VI are shown in
Fig. S8 in ESIw, along with their relative energies and dis-
sociation energies for NH3 loss. The three lowest-energy
structures considered FI_95–FIII_95 are methylated proto-
nated 1,3-diazine ions, which are very similar in structure,
energy, and binding energy. However, their formation prob-
ably involves high activation barriers, because NH3 loss is
followed by an expansion of the ﬁve-membered imidazole ring
to a six-membered diazine ring. Thus, the most likely structure
of the m/z = 95 fragment is believed to be FIV_95, which is
75 kJ mol1 higher in energy than FI_95 but can readily be
generated by a simple H-shift after NH3 elimination. At the
present stage, it is however diﬃcult to safely identify the
actual structure of the fragment ion observed in the IRMPD
experiment. Further mass spectrometric and spectroscopic
experiments90 for the m/z = 95 ion to conﬁrm its structure
are beyond the scope of the present work.
3.2 Eﬀects of protonation
To evaluate the eﬀects of protonation, we compare the proper-
ties of the most stable isomer of histamineH+ (A) with those
of the most stable structure A(n) of neutral histamine identiﬁed
by microwave spectroscopy,26,27 and the current quantum
chemical calculations (Fig. S9 in ESIw). In this comparison,
A is generated from A(n) by adding a proton to Nt of the
imidazole ring (Fig. 6). Both structures are signiﬁcantly stabi-
lized by intramolecular Np–H(+)  Na hydrogen bonds,
although the strength of the ionic H-bond is roughly ﬁve times
stronger (B70 kJ mol1) than in the neutral species (B10–
20 kJ mol1, Fig. S9 in ESIw).27 The energy diﬀerence between
A and A(n) corresponds to the proton aﬃnity of histamine and
amounts to 1005.4 (1007.0) kJ mol1 at the B3LYP(MP2)/
cc-pVDZ levels. These values compare favourably with the
tabulated experimental value of 999.8 kJ mol1,29,91 although
the latter value is not isomer speciﬁc.
Selected structural parameters of A and A(n) are compared
in Table 4 and Fig. S10 in ESI.w The rotational constants
calculated for A(n) (Ae = 4934 MHz, Be = 1395 MHz,
Ce = 1138 MHz) agree well with those measured for the most
stable species by microwave spectroscopy (A0 = 4952 MHz,
Be = 1392 MHz, Ce = 1141 MHz),
26 conﬁrming that the
B3LYP/cc-pVDZ reliably describes its structure. Fig. S11 in
ESIw provides details of the NBO charge distribution in A and
A(n). As expected, in neutral A(n) both the imidazole ring and
the side chain are essentially neutral. As already mentioned,
addition of the proton to Nt implies that the imidazole ring in
A carries nearly all positive charge (+0.84 e), with an increase
of 0.05 e of the positive partial charge on the proton in the
intramolecular Np–H(+)  Na H-bond. This drastic change in
the charge distribution is responsible for the substantial
increase in the strength of the H-bond upon protonation.
The ionic H-bond is much shorter than the neutral one
(1.79 vs. 2.14 A˚) and more linear (y = 136 vs. 1261). As a
consequence of the stronger H-bond in A, the Np–H proton
donor bond is elongated in A by 0.04 A˚. Of course, protona-
tion of the imidazole ring also aﬀects its geometry, and the
main bond length changes include a contraction of the Np–C2
bond (0.034 A˚) and an elongation of the neighbouring C2–Nt
bond (0.021 A˚). All other bond length changes are less than
0.01 A˚, and particularly the geometry changes of the ethyl-
amine side chain are modest.
The structural changes upon protonation directly translate
into diﬀerences in the vibrational spectra of A and A(n). As no
experimental IR spectrum is available for free histamine,
comparison can only be performed between the calculated
spectra (Fig. 6, Table 1). The major diﬀerences are brieﬂy
discussed. The excess proton attached to Nt gives rise to two
additional fundamentals in the ﬁngerprint range, namely the
out-of-plane and in-plane NH bends at gNH= 671 and bNH=
1471 cm1. The gNH mode is experimentally observed as an
intense isolated transition at 685 cm1 (band B), whereas bNH
is weakly seen at 1453 cm1 (bandM). The in-plane CC stretch
mode n5(Im) increases in frequency by 46 cm
1 from 1577 to
1623 cm1, due to the protonation-induced contraction of the
C4C5 bond, and is detected as intense band O at 1598 cm1.
Similarly, the n6(Im) frequency increases by 53 cm
1 from
1474 to 1527 cm1 (band N at 1515 cm1) because of the
substantial contraction of the C2–Np bond upon protonation.
As a consequence of the drastic increase in the intramolecular
H-bond strength, the frequencies of the in-plane and out-of-
plane NH bends (bNH and gNH) of the Np–H
+  Na proton
bridge shift signiﬁcantly to higher frequency and appear with
enhanced IR intensity. The eﬀect is much larger for gNH
Table 4 Selected bond lengths (A˚) and angles (1) of the A(n) and A isomers of neutral and protonated histamine (Fig. 6) evaluated at the B3LYP/
cc-pVDZ levela
Bond Histamine A(n) HistamineH+ A Db Angle Histamine A(n) HistamineH+ A Db
Np–C2 1.365 1.331 0.034 Np–C2–Nt 111.9 107.3 4.6
C2–Nt 1.320 1.341 0.021 C2–Nt–C4 104.9 109.8 4.9
Nt–C4 1.379 1.385 0.006 Nt–C4–C5 111.0 106.5 4.5
C4–C5 1.381 1.373 0.008 C4–C5–Np 104.6 106.2 1.6
C5–Np 1.381 1.386 0.005 C5–Np–C2 107.5 110.2 2.7
C5–C6 1.500 1.501 0.001 Np–C5–C6–C7 42.5 36.2 6.3
C6–C7 1.537 1.541 0.004 C5–C6–C7–Na 64.2 57.9 6.3
C7–Na 1.477 1.484 0.007
Na–H 2.140 1.790 0.350
Np–H 1.020 1.059 0.039
Nt–H 1.016
a Further values are provided in Fig. S10 in ESI.w b D denotes the structural change upon protonation, A–A(n).
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(758 - 1078 cm1), which is observed as intense band G at
1075 cm1. The blueshift for the bNH transition is less pro-
nounced (1084 - 1117 cm1), and the band is observed at
1107 cm1 (band H). The fact that the experimental IRMPD
spectrum reproduces these b/gNH frequencies to within
10 cm1 provides evidence that the B3LYP/cc-pVDZ level
describes the intramolecular Np–H+  Na H-bond to satis-
factory accuracy. Further noticeable redshifts upon protona-
tion include Dn19(Im) = 45 cm1 for the out-of-plane ring
deformation (652 - 607 cm1) experimentally observed at
607 cm1 (band A), and a highly coupled mode giving rise to
band I at 1293 cm1 (1359 - 1296 cm1, Dn = 63 cm1).
Comparison of the spectrum calculated for A(n) with that
taken from the NIST data base86 is provided in Fig. S12 in
ESI.w The NIST spectrum is a solid-state spectrum taken in
mineral oil mull and partly contaminated by oil resonances.
In any case, it looks diﬀerent in appearance from that pre-
dicted for A(n) consistent with the hypothesis that gas and
condensed phase structures are diﬀerent for histamine(H+).
4. Concluding remarks
The IRMPD spectrum of isolated histamineH+ recorded in
the ﬁngerprint range, in combination with quantum chemical
calculations, provides the ﬁrst experimental information about
the tautomeric and conformational structure of this funda-
mental protonated neurotransmitter molecule in the gas phase.
The experimental spectrum is consistent with isomer A being
by far the dominant carrier. This imidazolium-type isomer is
calculated to be the most stable isomer of histamineH+.
Protonation occurs at the basic N atom of the imidazole ring,
and the resulting imidazolium ion is substantially stabilized by
an intramolecular Np–H+  Na hydrogen bond (B50 kJ mol1)
to the lone pair of the terminal amino group of the aliphatic
ethylamine side chain in gauche conformation. Signiﬁcantly, the
structure found in the gas phase is diﬀerent from those identiﬁed
in the liquid and crystalline phases, which all are protonated at
the amino group leading to ammonium isomers in gauche and/or
trans conformation. This diﬀerence emphasizes the important
eﬀects of solvation and counter ions on the structure of
histamineH+. The lowest-energy ammonium isomer of isolated
histamineH+ (isomer B) can be derived from A by simple proton
transfer along the Np–H+  Na proton bridge involving barriers
of 5–15 kJ mol1. Although the energy diﬀerence between A and
B is calculated to be small (1–10 kJ mol1 depending on the level
of theory), the experimental IRMPD spectrum does not show
any conclusive evidence for the presence of isomer B, suggesting
only minor population in the sampled ion cloud. Clearly, higher-
level calculations and multidimensional anharmonic calculations
are required to reliably determine the free energy proﬁle of this
interesting proton-transfer double-well potential connecting A
and B with high accuracy. The established structural transition
from an imidazolium to an ammonium ion upon aqueous
solvation makes histamineH+ an ideal target for spectroscopic
characterization of microhydrated histamineH+ clusters,
histamineH+–(H2O)n, in order to follow the proton transfer upon
hydration in a stepwise fashion by systematically increasing n.
Similarly, the small barriers for proton transfer and the large
eﬀects of anharmonicity make isolated and microhydrated
histamineH+ an attractive model system for molecular dynamic
simulations to evaluate the eﬀects of temperature, anharmoni-
city, and (micro-)solvation on structure, energy, and the appear-
ance of the IR spectrum.92 Finally, spectroscopic studies of
histamineH+–(H2O)n and their deuterated species in the NH
and OH stretch range85,93 will provide further insight into the
structure and energetics of the intra- and intermolecular H-bonds
in these biophysically interesting species. Comparison between
histamineH+ and histamine reveals the eﬀects of protonation on
the structure, energy, intramolecular hydrogen bonding, and IR
spectrum. Unfortunately, IR spectra of neutral histamine are
lacking so far though recent progress toward IR spectroscopy of
non-volatile neutral neurotransmitters in molecular beams will
change this situation in the near future.94,95 In general, the results
for histamineH+ are similar to conclusions for the related
histidineH+ molecule reached from mass spectrometry and
quantum chemistry,96 although (IR) spectra of the protonated
amino acid analogue in the gas phase have not been reported yet.
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